Home/Filings/4/0001493152-22-008029
4//SEC Filing

Amin Dipti 4

Accession 0001493152-22-008029

CIK 0000876343other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 4:15 PM ET

Size

5.1 KB

Accession

0001493152-22-008029

Insider Transaction Report

Form 4
Period: 2022-03-28
Amin Dipti
Director
Transactions
  • Purchase

    Common Shares, no par value

    2022-03-28$1.63/sh+35,000$57,05035,000 total
Footnotes (1)
  • [F1]The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.48 to not more than $1.66. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

Documents

1 file

Issuer

Lineage Cell Therapeutics, Inc.

CIK 0000876343

Entity typeother

Related Parties

1
  • filerCIK 0001856708

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:15 PM ET
Size
5.1 KB